Drug
Cerebrolysin clinical trials
Also written Renacenz.
- studies test it
- 34
- open now
- 10
- in phase 3
- 6
- first study started
- 2004
Keep track of what changes. Save the cerebrolysin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Brand
Combined with it in one product
Studies by the year they started
33 studies that test it; most in 2023 (7)
| Year | Studies |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2010 | 1 |
| 2011 | 3 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 3 |
| 2020 | 1 |
| 2021 | 5 |
| 2022 | 1 |
| 2023 | 7 |
| 2024 | 2 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 3
- Phase 2
- 10
- Phase 3
- 6
- Phase 4
- 12
- No phase
- 5
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 8 · Other 26
Ever Neuro Pharma GmbH (8) · Ain Shams University (2) · Mansoura University Children Hospital (2) · Samsung Medical Center (2) · Clinical Institute of the Brain, Russia (2) · Medical University of Lublin (2) · Sherifa Ahmed Hamed (1) · Assiut University (1)
Often tested with
Tested in the same studies.
Amantadine (1) · Butylphthalide (1) · Cytidine Diphosphate Choline (1) · Glycerylphosphorylcholine (1) · Donepezil (1) · Prednisolone (1)
Studies
Open first, then newest update. How each study uses cerebrolysin is read from its arms, and is right about nine times in ten.
Testing it · 34
- Combined Acupuncture-Based Therapy for Rehabilitation After Ischemic StrokeNot yet recruitingNot applicableNational Hospital of Acupuncture, VietnamNCT07846488Written as Cerebrolysin
- Cerebrolysin After Reperfusion in Extended-window EndoVascular ThrombectomyNot yet recruitingPhase 2Chang Gung Memorial HospitalNCT06339411Written as Cerebrolysin
- Efficacy and Safety of Cerebrolysin on Prolonged Disorders of ConsciousnessRecruitingPhase 4Konkuk University Medical CenterNCT04427241Written as Cerebrolysin
- Efficacy of Prednisolone Versus Cerebrolysin in the Treatment of Bell's PalsyRecruitingPhase 1/2October 6 UniversityNCT05821075Written as Cerebrolysin
- Cerebrolysin in Critically Ill Patients With DeliriumEnrolling by invitationNot applicableMedical University of LublinNCT06677502Written as Cerebrolysin
- Cerebrolysin as an Add-On Therapy to Standard Treatment of Basilar Artery OcclusionNot yet recruitingEarly Phase 1University Hospital Sestre MilosrdniceNCT06489925Written as Cerebrolysin
- Effect of Cerebrolysin on the Blood Brain Barrier in Patients With Diabetes and Ischemic StrokeRecruitingPhase 4Hospital Universitario Dr. Jose E. GonzalezNCT06273020Written as Cerebrolysin
- Cerebrolysin in Prevention of Postoperative Delirium in Cardiac SurgeryEnrolling by invitationNot applicableMedical University of LublinNCT05864677Written as Cerebrolysin
- CERebrolysine Effect on Blood-brain Barrier in acUte Ischemic StrokeRecruitingPhase 4Poznan University of Medical SciencesNCT06078215Written as Cerebrolysin
- A Prospective, Trial About Safety and Efficacy of Combined Treatment With Cerebrolysin in Acute Ischemic Hemispheric Stroke Patients Undergoing EndoVascular Treatment (EVT)RecruitingNot applicableShaare Zedek Medical CenterNCT06070753Written as Cerebrolysin
- Combined Cerebrolysin and Amantadine Sulfate Administration for Patients With Traumatic Brain Injury in the ICUCompletedPhase 3Ain Shams UniversityNCT06052787Written as Cerebrolysin
- CERebrolysin in CADASILActive, not recruitingPhase 2Ever Neuro Pharma GmbHNCT05755997Written as Cerebrolysin
- Clinical Characteristics and Treatment of Anosmia and Ageusia Due to SARS-CoV2 VariantsCompletedPhase 4Sherifa Ahmed HamedNCT06208540Written as Cerebrolysin
- A Clinical Trial to Evaluate the Safety and Efficacy of 20 ml Cerebrolysin in Patients With Vascular DementiaCompletedPhase 4Ever Neuro Pharma GmbHNCT00947531Written as Cerebrolysin
- The Safety and Efficacy of Cerebrolysin in Patients With Acute Ischemic StrokeCompletedPhase 4Ever Neuro Pharma GmbHNCT00868283Written as Cerebrolysin
- Cerebrolycin for Treatment of Covid-related Anosmia and AgeusiaCompletedPhase 3Assiut UniversityNCT04830943Written as Cerebrolysin
- Efficacy of Cerebrolysin Treatment as an add-on Therapy to Mechanical Thrombectomy in Acute Ischemic Stroke.Status unknownPhase 3Military Institute od Medicine National Research InstituteNCT04904341Written as Cerebrolysin
- IMPULSE - StIMulation of Brain Plasticity to Improve Upper Limb Recovery After StrokETerminatedPhase 2Ever Neuro Pharma GmbHNCT04124367Written as Cerebrolysin
- Hair Repigmentation During Cerebrolysin TherapyCompletedNot applicableUniversidad Autonoma de Nuevo LeonNCT05288465Written as Cerebrolysin
- Early Administration of Cerebrolysin on the Outcome of Patients With Acute Stroke Undergoing EVTStatus unknownPhase 2/3Pomeranian Medical University SzczecinNCT05124353Written as Cerebrolysin
See all 34 studies that test cerebrolysin →
As the comparator · 1 — what is tested is compared with cerebrolysin
Codes
What other systems call cerebrolysin · ClinicalTrials.gg INT002384
- MeSH (NLM) C006952cerebrolysinConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 37KZM6S21GCEREBROLYSINConfirmed FDA, NLM, Wikidata
- Wikidata Q19946892cerebrolysinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C221892CerebrolysinOne source FDA
- DrugBank DB16599One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C006952 | cerebrolysin | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 37KZM6S21G | CEREBROLYSIN | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q19946892 | cerebrolysin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C221892 | Cerebrolysin | One source FDA |
| DrugBank | DB16599 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.